TABLE 3.
Kinetic properties of the SHV-13 enzyme from K. pneumoniae 803
| Substrate | Km (μM) | Relative Vmaxa of SHV-13 (%) | Vmax/Kma ratio | Relative Vmaxa of SHV-1 (%)d |
|---|---|---|---|---|
| Benzylpenicillin | 10 | 100 | 100 | 100 |
| Ampicillin | 28 | 178 | 64 | 150 |
| Piperacillin | 18 | 136 | 76 | |
| Oxacillin | NDb | NLKc | ND | <0.5 |
| Cephaloridine | 97 | 176 | 18 | 48 |
| Cefuroxime | 61 | 11 | 1.8 | ND |
| Ceftriaxone | 11 | 12 | 11 | ND |
| Cefotaxime | 52 | 27 | 5.2 | 0.18 |
| Ceftazidime | 91 | 0.38 | 0.42 | 0.02 |
| Cefoxitin | ND | <0.1 | ND | 0 |
| Aztreonam | 77 | 0.66 | 0.86 | <0.38 |
| Imipenem | ND | <0.1 | ND | ND |
Relative to that for benzylpenicillin, which was set at 100%.
ND, not determined.
NLK, nonlinear kinetics.
From reference 2.